On August 11, Rocket Lab USA, Inc. fell 8.35% in pre-market trading, trading at approximately $73.66/share, with turnover of $4.56 million. The decline follows the company's Q2 earnings release after the prior session's close, which delivered mixed results and disappointed on profitability metrics.

Rocket Lab reported Q2 revenue of $234.1 million, up 62% year-over-year and slightly beating the consensus estimate of $231.6 million. However, the company posted a loss of $0.08 per share, missing analyst expectations of $0.06-$0.07. More critically, Q3 GAAP gross margin guidance of 29%-31% came in sharply below the Street's 37.6% average estimate, with management citing changes in product sales mix. Additionally, the company signaled potential new delays for its Neutron rocket program, a cornerstone of its long-term growth strategy.

Despite record backlog of $2.36 billion and a recent $397 million U.S. Space Force contract, the earnings miss combined with significantly lower margin guidance and Neutron delay risk dominated market sentiment, driving the pre-market selloff.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)